As
filed with the Securities and Exchange Commission on May 31, 2022
Registration
No. 333-
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
S-3
REGISTRATION
STATEMENT UNDER
THE
SECURITIES ACT OF 1933
SUNWORKS,
INC.
(Exact
name of registrant as specified in its charter)
Delaware |
|
01-0592299 |
(State
or other jurisdiction of
incorporation
or organization) |
|
(I.R.S.
Employer
Identification
Number) |
1555
Freedom Boulevard
Provo,
UT 84604
(385)
497-6955
(Address,
including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Gaylon
Morris
Chief
Executive Officer
Sunworks,
Inc.
1555
Freedom Boulevard
Provo,
UT 84604
(385)
497-6955
(Name,
address, including zip code, and telephone number, including area code, of agent for service)
Copies
to:
Christopher D. Ivey, Esq.
Jason Lee, Esq.
Stradling Yocca Carlson & Rauth, P.C.
660 Newport Center Drive, Suite 1600
Newport Beach, California 92660
(949) 725-4000
Approximate
date of commencement of proposed sale to public: From time to time after this Registration Statement becomes effective.
If
the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check
the following box. ☐
If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933, as amended, or the Securities Act, other than securities offered only in connection with dividend or interest
reinvestment plans, check the following box. ☒
If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the same
offering. ☐
If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If
this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective
upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☐
If
this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional
securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller
reporting company,” and “emerging growth company” in Rule 12b-2 of the Securities and Exchange Act of 1934, as amended.
Large
accelerated filer |
|
☐ |
|
Accelerated
filer |
|
☐ |
Non-accelerated
filer |
|
☒ |
|
Smaller
reporting company |
|
☒ |
|
|
|
|
Emerging
growth company |
|
☐ |
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of Securities Act. ☐
The
registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the
Registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective
in accordance with Section 8(a) of the Securities Act or until the registration statement shall become effective on such date as
the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.
The
information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement
filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not
soliciting an offer to buy these securities in any state where the offer or sale is not permitted.
PRELIMINARY
PROSPECTUS
SUBJECT
TO COMPLETION, DATED May 31, 2022
$75,000,000
SUNWORKS,
INC.
Common
Stock
Preferred Stock
Warrants
Units
We
may offer and sell, from time to time in one or more offerings, any combination of common stock, preferred stock, warrants or units having
an aggregate initial offering price not to exceed $75,000,000. The preferred stock may be convertible into shares of our common stock
or shares of our preferred stock. The warrants may be exercisable for shares of our common stock or shares of our preferred stock. The
units may consist of any combination of the other types of securities described in this prospectus.
This
prospectus provides a general description of the securities we may offer. Each time we sell a particular class of securities, we will
provide specific terms of the securities offered in a supplement to this prospectus. The prospectus supplement may also add, update or
change information in this prospectus. You should read this prospectus and any prospectus supplement, as well as the documents incorporated
by reference or deemed to be incorporated by reference herein or therein, carefully before you invest in any of the securities offered
pursuant to this prospectus.
This
prospectus may not be used to offer or sell our securities unless accompanied by a prospectus supplement relating to the offered securities.
These
securities may be sold directly by us, through dealers or agents designated from time to time, to or through underwriters or dealers
or through a combination of these methods on a continuous or delayed basis. For additional information on the methods of sale, you should
refer to the section entitled “Plan of Distribution” in this prospectus. We will describe the plan of distribution for any
particular offering of our securities in a prospectus supplement. If any agents, underwriters or dealers are involved in the sale of
any securities with respect to which this prospectus is being delivered, we will set forth in a prospectus supplement the names of such
agents or underwriters and any applicable fees, commissions, discounts and over-allotment options. We will also set forth in a prospectus
supplement the price to the public of such securities and the net proceeds that we expect to receive from such sale.
Our
common stock is listed on the NASDAQ Capital Market and traded under the symbol “SUNW.” On May 27, 2022, the last reported
sale price for our common stock on the NASDAQ Capital Market was $1.99 per share.
INVESTING
IN OUR SECURITIES INVOLVES A HIGH DEGREE OF RISK. YOU SHOULD REVIEW CAREFULLY THE RISKS AND UNCERTAINTIES DESCRIBED UNDER THE HEADING
“RISK FACTORS” BEGINNING ON PAGE 5 OF THIS PROSPECTUS, AS WELL AS THE RISKS AND UNCERTAINTIES DESCRIBED UNDER A SIMILAR HEADING
IN ANY APPLICABLE PROSPECTUS SUPPLEMENT AND IN THE DOCUMENTS THAT WE INCORPORATE BY REFERENCE HEREIN OR THEREIN.
Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed
upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.
The
date of this prospectus is ________________, 2022
TABLE
OF CONTENTS
PROSPECTUS
ABOUT
THIS PROSPECTUS
This
prospectus is part of a registration statement that we filed with the Securities and Exchange Commission, or the SEC, using a “shelf”
registration process. Under this shelf registration process, we may from time to time offer and sell any combination of the securities
described in this prospectus in one or more offerings with an aggregate initial offering price not to exceed $75,000,000. We have provided
to you in this prospectus a general description of the securities we may offer. Each time we offer or sell any of our securities under
this prospectus, we will, to the extent required by law, provide a prospectus supplement that will contain specific information about
the terms of the offering.
References
herein to “we,” “us,” “Sunworks,” and “the Company” are to Sunworks, Inc. and its wholly-owned
subsidiaries, Sunworks United Inc. (“Sunworks United”), Commercial Solar Energy, Inc. (“CSE”), and Solcius LLC.
(“Solcius”)
We
may add, update or change any of the information contained in this prospectus or in any accompanying prospectus supplement we may authorize
to be delivered to you. To the extent there is a conflict between the information contained in this prospectus and any accompanying prospectus
supplement, you should rely on the information in the prospectus supplement, provided that if any statement in one of these documents
is inconsistent with a statement in another document having a later date—for example, a document incorporated by reference in this
prospectus or any prospectus supplement—the statement in the document having the later date modifies or supersedes the earlier
statement. Any statement so modified will be deemed to constitute a part of this prospectus only as so modified, and any statement so
superseded will be deemed not to constitute a part of this prospectus. This prospectus, together with any accompanying prospectus supplement,
includes all material information relating to an offering pursuant to this registration statement.
You
should rely only on the information contained in this prospectus, in any accompanying prospectus supplement, or in any document incorporated
by reference herein or therein. We have not authorized anyone to provide you with any different information. We take no responsibility
for, and can provide no assurance as to the reliability of, any other information that others may provide to you. The information contained
in this prospectus, in any applicable prospectus supplement, and in the documents incorporated by reference herein or therein is accurate
only as of the date such information is presented. Our business, financial condition, results of operations and future prospects may
have changed since those respective dates.
This
prospectus and any accompanying prospectus supplement does not constitute an offer to sell or the solicitation of an offer to buy any
securities other than the registered securities to which they relate, nor does this prospectus and any accompanying prospectus supplement
constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction to any person to whom it is unlawful
to make such offer or solicitation in such jurisdiction. This prospectus may not be used to offer or sell our securities unless accompanied
by a prospectus supplement relating to the offered securities.
The
registration statement containing this prospectus, including the exhibits to the registration statement, provides additional information
about us and the securities offered pursuant to this prospectus. For a more complete understanding of the offering of the securities,
you should refer to the registration statement, including its exhibits. The registration statement can be read on the SEC’s website
or at the SEC’s offices mentioned under the heading “Where You Can Find More Information.”
SPECIAL
NOTE REGARDING FORWARD-LOOKING INFORMATION
This
prospectus, any accompanying prospectus supplement, and the documents incorporated by reference herein and therein, contain forward-looking
statements within the meaning of the federal securities laws. These forward-looking statements are intended to qualify for the safe harbor
from liability established by the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical
fact included in this prospectus, any accompanying prospectus supplement, or the documents incorporated by reference herein or therein,
are forward looking statements. We have attempted to identify forward-looking statements by using words such as “may,” “believe,”
“will,” “could,” “project,” “anticipate,” “expect,” “estimate,”
“should,” “continue,” “potential,” “plan,” “forecasts,” “goal,”
“seek,” “intend,” other forms of these words or similar words or expressions or the negative thereof.
Our
forward-looking statements are based on our management’s current assumptions and expectations of future events and trends, which
affect or may affect our business, strategy, operations or financial performance. Although we believe that these forward-looking statements
are based upon reasonable assumptions, they are subject to numerous known and unknown risks and uncertainties and are made in light of
information currently available to us. Many important factors, in addition to the factors described in this prospectus, may materially
and adversely affect our results as indicated in our forward-looking statements. You should read this prospectus, any accompanying prospectus
supplement, and the documents we incorporate by reference herein and therein, completely and with the understanding that our actual future
results may be materially different from and worse than what we expect.
Moreover,
we operate in an evolving environment. New risk factors and uncertainties emerge from time to time and it is not possible for our management
to predict all risk factors and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any
factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.
Forward-looking
statements speak only as of the date they were made, and, except to the extent required by law or the rules of the NASDAQ Stock Market,
we undertake no obligation to update or review any forward-looking statement because of new information, future events or other factors.
You should, however, review the risks and uncertainties we describe in the reports we will file from time to time with the SEC, after
the date of this prospectus. See the information included under the heading “Where You Can Find More Information.”
Forward-looking
statements involve risks and uncertainties and are not guarantees of future performance. As a result of the risks and uncertainties described
above, the forward-looking statements discussed in this prospectus might not occur and our future results and performance may differ
materially from the information provided in these forward-looking statements due to, but not limited to, the factors mentioned above.
Because of these uncertainties, you should not place undue reliance on these forward-looking statements when making an investment decision.
We
qualify all of our forward-looking statements by these cautionary statements.
ABOUT
THE COMPANY
The
following is a summary of what we believe to be the most important aspects of our business. Please read the additional information in
the sections entitled “Incorporation of Certain Documents by Reference” and “Where You Can Find More Information.”
Overview
We
provide photovoltaic (“PV”) and battery based power and storage systems for the residential and commercial markets. Commercial
projects include commercial, agricultural, industrial and public works projects. We operate in several residential and commercial markets
including California, Utah, Nevada, Arizona, New Mexico, Texas, Colorado, Minnesota, Wisconsin, Massachusetts, Rhode Island, New York,
Pennsylvania, New Jersey and South Carolina. Through our operating subsidiaries, we design, arrange financing, integrate, install, and
manage systems ranging in size from 2kW (kilowatt) for residential projects to multi-MW (megawatt) systems for larger commercial and
public works projects. Commercial installations have included installations at office buildings, manufacturing plants, warehouses, service
stations, churches, and agricultural facilities such as farms, wineries, and dairies. Public works installations have included school
districts, local municipalities, federal facilities and higher education institutions.
On
April 8, 2021, we, through our operating subsidiary Sunworks United (the “Buyer”), acquired all of the issued and outstanding
membership interests (the “Acquisition”) of Solcius, LLC (“Solcius”), from Solcius Holdings, LLC (“Seller”).
Located in Provo, Utah, Solcius is a full-service, residential solar systems provider. The transaction creates a national solar power
provider with a presence now in 15 states, including California, Utah, Nevada, Arizona, New Mexico, Texas, Colorado, Minnesota, Wisconsin,
Massachusetts, Rhode Island, New York, Pennsylvania, New Jersey and South Carolina. The Company believes the transaction enhances economies
of scale, leading to better access to suppliers, vendors and financial partners, as well as marketing and customer acquisition opportunities.
The
Acquisition was consummated on April 8, 2021 pursuant to a Membership Interest Purchase Agreement, dated as of April 8, 2021 (the “Purchase
Agreement”), by and between Buyer and Seller. The purchase price for Solcius consisted of $51.75 million in cash, subject to post-closing
adjustments related to working capital, cash, indebtedness and transaction expenses.
Residential
Solar
Through
our Residential Solar operating subsidiary, we design, arrange financing, integrate, install, and manage systems, primarily for residential
homeowners. We sell residential solar systems through multiple channels, including our network of sales channel partners, and our growing
direct sales channel strategy. We operate in several residential and commercial markets including California, Utah, Nevada, Arizona,
New Mexico, Texas, Colorado, Minnesota, Wisconsin and South Carolina. We have direct sales or operations personnel in California, Nevada,
Utah, Arizona, New Mexico, Texas, Colorado, South Carolina, Wisconsin and Minnesota.
Commercial
Solar
Through
our Commercial Solar Energy operating subsidiaries, we design, arrange financing, integrate, install, and manage systems ranging in size
from 2kW (kilowatt) for residential projects to multi-MW (megawatt) systems for larger commercial and public works projects. Commercial
installations have included installations at office buildings, manufacturing plants, warehouses, service stations, churches, and agricultural
facilities such as farms, wineries, and dairies. Public works installations have included school districts, local municipalities, federal
facilities and higher education institutions. Commercial Solar primarily operates primarily in California.
Corporate
Information
Our
principal executive offices are located at 1555 Freedom Blvd, Provo, Utah 84604 and our telephone number is (385) 497-6955. Our web site
address is www.sunworksusa.com. Information contained in or accessible through our website does not constitute part of,
and is not incorporated into, this prospectus.
Implications
of Being a Smaller Reporting Company
We
are a “smaller reporting company” as defined in the Securities Exchange Act of 1934, or the Exchange Act, and have elected
to take advantage of certain of the scaled disclosures available to smaller reporting companies.
RISK
FACTORS
Investing
in our securities involves a high degree of risk. Before making an investment decision, you should carefully consider the risks described
in the sections entitled “Risk Factors” in our most recent Annual Report on Form 10-K and subsequent Quarterly Report on
Form 10-Q, as filed with the SEC, which are incorporated by reference in this prospectus in their entirety, as well as any amendments
or updates to our risk factors reflected in subsequent filings with the SEC, including any applicable prospectus supplement. If any of
these risks actually occur, our business, financial condition, results of operations and future prospects could be materially and adversely
affected. In that case, the trading price of our securities could decline and you might lose all or part of your investment. For more
information, see “Where You Can Find More Information.”
The
risks and uncertainties we have described are not the only ones we face. Additional risks and uncertainties not presently known to us
or that we currently deem immaterial may also affect our business, financial condition or results of operations.
This
prospectus and the documents we incorporate by reference in this prospectus contain forward-looking statements that involve risks and
uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain
factors, including the risks and uncertainties mentioned elsewhere in this prospectus. For more information, see “Special Note
Regarding Forward-Looking Information.”
USE
OF PROCEEDS
We
will retain broad discretion over the use of the net proceeds from the sale of our securities offered hereby. Except as described in
any prospectus supplement or any related free writing prospectus that we may authorize to be provided to you, we currently intend to
use the net proceeds from the sale of our securities offered hereby for working capital and general corporate purposes, which may include
capital expenditures, sales and marketing and general and administrative expenses. We may also use a portion of the net proceeds to acquire
or invest in businesses, products and technologies that are complementary to our own, although we have no current plans, commitments
or agreements with respect to any such acquisitions or investments as of the date of this prospectus. We will set forth in the applicable
prospectus supplement or free writing prospectus our intended use for the net proceeds received from the sale of any securities sold
pursuant to the prospectus supplement or free writing prospectus. Our management will have broad discretion in the allocation of the
net proceeds from this offering.
Pending
the application of the net proceeds, we may invest the net proceeds in short-term, investment grade, interest-bearing securities, certificates
of deposit or direct or guaranteed obligations of the U.S. government.
THE
SECURITIES WE MAY OFFER
We
may offer and sell, from time to time in one or more offerings, any combination of common stock, preferred stock, warrants, and/or units
having an aggregate initial offering price not to exceed $75,000,000. The preferred stock may be convertible into shares of our common
stock or shares of our preferred stock. The warrants may be exercisable for shares of our common stock or shares of our preferred stock.
The units may consist of any combination of the other types of securities described in this prospectus. In this prospectus, we refer
to the common stock, preferred stock, warrants and units that we may offer collectively as “securities.”
This
prospectus provides a general description of the securities we may offer. Each time we sell any of our securities under this prospectus,
we will, to the extent required by law, provide a prospectus supplement that will contain specific information about the terms of the
offering. The prospectus supplement may also add, update or change information in this prospectus. For more information, see “About
this Prospectus.”
DESCRIPTION
OF CAPITAL STOCK
The
following is a summary of all material characteristics of our capital stock as set forth in our certificate of incorporation, as amended,
and bylaws. The summary does not purport to be complete and is qualified in its entirety by reference to our certificate of incorporation,
as amended, and bylaws, copies of which have been filed as exhibits to our SEC filings. For more information, see “Where You Can
Find More Information.”
Common
Stock
We
may issue shares of our common stock from time to time. We are authorized to issue 50,000,000 shares of common stock, par value $0.001
per share. As of May 27, 2022, there were 32,928,989 shares of common stock issued and outstanding. The holders of common stock are entitled
to one vote for each share held of record on all matters submitted to a vote of the stockholders. The holders of common stock are not
entitled to cumulative voting rights with respect to the election of directors, and as a consequence, minority stockholders will not
be able to elect directors on the basis of their votes alone. Subject to preferences that may be applicable to any shares of preferred
stock issued in the future, holders of common stock are entitled to receive dividends on a pro rata basis as may be declared by our board
out of funds legally available therefor. In the event of a liquidation, dissolution or winding up of our Company, holders of our common
stock are entitled to share ratably in all assets remaining after payment of liabilities and the liquidation preference of any then outstanding
preferred stock. Holders of common stock have no preemptive rights and no right to convert their common stock into any other securities.
There are no redemption or sinking fund provisions applicable to the common stock. All outstanding shares of common stock are, and all
shares of common stock to be outstanding upon completion of this offering will be, fully paid and nonassessable.
Preferred
Stock
As
of May 31, 2022, there were no shares of our preferred stock outstanding. Pursuant to the terms of our certificate of incorporation,
as amended, our board of directors is authorized, subject to limitations prescribed by Delaware law, to issue up to 5,000,000 shares
of preferred stock, par value $0.001 per share, in one or more series, to establish from time to time the number of shares to be included
in each series, and to fix the designation, powers, preferences and rights of the shares of each series and any of its qualifications,
limitations or restrictions, in each case without further action by our stockholders. Our board of directors also can increase or decrease
the number of shares of any series of preferred stock, but not below the number of shares of that series then outstanding. Our board
of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power
or other rights of the holders of our common stock. The issuance of preferred stock, while providing flexibility in connection with possible
acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in
our control or the removal of management and could adversely affect the market price of our common stock and the voting and other rights
of the holders of our common stock.
Whenever
preferred stock is to be offered and sold pursuant to this prospectus, we will file a prospectus supplement relating to that offer and
sale which will specify (in each case to the extent applicable):
| ● | the
title and stated value of the preferred stock; |
| | |
| ● | the
number of shares of the preferred stock offered, the liquidation preference per share and
the offering price of the preferred stock; |
| | |
| ● | the
dividend rate, period and payment date, and method of calculation of dividends; |
| | |
| ● | whether
dividends are cumulative or non-cumulative and, if cumulative, the date from which dividends
will accumulate; |
| | |
| ● | any
listing of the preferred stock on any securities exchange; |
| | |
| ● | the
provision for redemption of the preferred stock; |
| ● | the
terms and conditions upon which the preferred stock will be convertible into any other class
of capital stock, including the conversion price; |
| | |
| ● | voting
rights of the preferred stock; |
| | |
| ● | preemption
rights; |
| | |
| ● | the
relative ranking and preferences of the preferred stock as to dividend rights and rights
upon the liquidation, dissolution or winding up of our affairs; |
| | |
| ● | limitations
on issuance of any class or series of preferred stock ranking senior to or on a parity with
the series of preferred stock as to dividend rights and rights if we liquidate, dissolve
or wind up our affairs; and |
| | |
| ● | any
other specific terms, preferences, rights or limitations of, or restrictions on, the preferred
stock. |
The
Delaware General Corporation Law, or DGCL, provides that the holders of preferred stock will have the right to vote separately as a class
on any proposed fundamental change in the rights of the preferred stock. This right is in addition to any voting rights that may be provided
for in the applicable certificate of designation.
All
shares of preferred stock offered by this prospectus will, when issued, be fully paid and nonassessable and will not have any preemptive
or similar rights.
Anti-Takeover
Effects of Provisions of Our Certificate of Incorporation, Bylaws and Delaware Law
We
are subject to the provisions of Section 203 of the Delaware General Corporation Law. Section 203 prohibits a publicly-held Delaware
corporation from engaging in a “business combination” with an “interested stockholder” for a period of three
years after the person became an interested stockholder, unless the business combination is approved in a prescribed manner. A “business
combination” includes mergers, asset sales and other transactions resulting in a financial benefit to the interested stockholder.
Subject to certain exceptions, an “interested stockholder” is a person who, together with affiliates and associates, owns,
or within the prior three years did own, 15% or more of the corporation’s outstanding voting stock.
Our
certificate of incorporation, as amended, authorizes the board of directors to issue up to 5,000,000 shares of preferred stock and to
determine the rights, preferences and privileges of these shares of preferred stock without any further vote or action by the stockholders,
and specifies that the authorized number of directors may be changed only by a resolution of the board of directors. The provisions described
above could have the effect of making it more difficult for a third-party to acquire a majority of our outstanding voting stock, or delay,
prevent or deter a merger, acquisition or tender offer in which our stockholders could receive a premium for their shares, a proxy contest
or other change in our management.
NASDAQ
Capital Market
Our
common stock is listed on NASDAQ Capital Market and traded under the symbol “SUNW.” On May 27, 2022, the last reported sale
price for our common stock on NASDAQ Capital Market was $1.99 per share.
Transfer Agent and Registrar
The
Transfer Agent and Registrar for our common stock is Continental Stock Transfer & Trust with an address at 1 State Street, 30th Floor,
New York NY 10004-1561.
DESCRIPTION
OF WARRANTS
We
may offer and sell, from time to time, warrants for the purchase of shares of common stock and/or shares of preferred stock. We may issue
warrants independently or together with common stock and/or preferred stock, and the warrants may be attached to or separate from those
securities. If we issue warrants, they will be evidenced by warrant agreements or warrant certificates issued under one or more warrant
agreements, which will be contracts between us and the holders of the warrants or an agent for the holders of the warrants. The forms
of warrant agreements or warrant certificates, as applicable, relating to the warrants will be filed as exhibits to the registration
statement of which this prospectus is a part and/or will be incorporated by reference from reports that we file with the SEC.
The
following summary of material provisions of the warrants and warrant agreements are subject to, and qualified in their entirety by reference
to, all of the provisions of the warrant agreement and warrant certificate applicable to a particular series of warrants. We urge you
to read the applicable prospectus supplement and any related free writing prospectus, as well as the complete warrant agreements and
warrant certificates that contain the terms of the warrants.
Whenever
warrants are to be issued and sold pursuant to this prospectus, we will file a prospectus supplement relating to that offer and sale
which will specify (in each case as applicable):
| ● | the
number of shares of common stock or preferred stock purchasable upon the exercise of warrants
to purchase such shares and the price at which such number of shares may be purchased upon
such exercise; |
| | |
| ● | the
designation, stated value and terms (including, without limitation, liquidation, dividend,
conversion and voting rights) of the series of preferred stock purchasable upon exercise
of warrants to purchase preferred stock; |
| | |
| ● | the
date, if any, on and after which the warrants and the related common stock or preferred stock
will be separately transferable; |
| | |
| ● | the
terms of any rights to redeem or call the warrants; |
| | |
| ● | the
date on which the right to exercise the warrants will commence and the date on which the
right will expire; and |
| | |
| ● | any
additional terms of the warrants, including terms, procedures, and limitations relating to
the exchange, exercise and settlement of the warrants. |
Each
warrant will entitle its holder to purchase the number of shares of common stock or preferred stock at the exercise price set forth in
(or calculable as set forth in) the applicable prospectus supplement. Unless we otherwise specify in the applicable prospectus supplement,
holders of the warrants may exercise the warrants at any time up to the specified time on the expiration date that we set forth in the
applicable prospectus supplement. After the close of business on the expiration date, unexercised warrants will become void.
A
holder of warrant certificates may exchange them for new warrant certificates of different denominations, present them for registration
of transfer, and exercise them as indicated in the applicable prospectus supplement. Until any warrants to purchase common stock or preferred
stock are exercised, the holders of the warrants will not have any rights of holders of the underlying common stock or preferred stock,
including any voting rights or any rights to receive dividends or payments upon any liquidation, dissolution or winding up on the common
stock or preferred stock, if any.
DESCRIPTION
OF UNITS
We
may offer and sell, from time to time, units comprised of one or more of the other securities described in this prospectus in any combination.
Each unit will be issued so that the holder of the unit is also the holder of each security included in the unit. Thus, the holder of
a unit will have the rights and obligations of a holder of each included security. If we issue units, they will be evidenced by unit
agreements or unit certificates issued under one or more unit agreements, which will be contracts between us and the holders of the units
or an agent for the holders of the units. The unit agreement under which a unit is issued may provide that the securities included in
the unit may not be held or transferred separately, at any time or at any time before a specified date. The forms of unit agreements
or unit certificates, as applicable, relating to the units will be filed as exhibits to the registration statement of which this prospectus
is part of and/or will be incorporated by reference from reports that we file with the SEC.
The
following summary of material provisions of the units and unit agreements are subject to, and qualified in their entirety by reference
to, all of the provisions of the unit agreements applicable to the units. We urge you to read the applicable prospectus supplement and
any related free writing prospectus, as well as the complete unit agreements that contain the terms of the units.
Whenever
units are to be issued and sold pursuant to this prospectus, we will file a prospectus supplement relating to that offer and sale which
will specify (in each case as applicable):
| ● | the
title of the series of units; |
| | |
| ● | identification
and description of the separate securities comprising the units; |
| | |
| ● | the
price or prices at which the units will be issued; |
| | |
| ● | the
date, if any, on and after which the securities comprising the units will be separately transferable;
and |
| | |
| ● | any
other terms of the units and their securities. |
PLAN
OF DISTRIBUTION
We
may sell our securities from time to time in any manner permitted by the Securities Act, including any one or more of the following ways:
| ● | through
agents; |
| ● | to
or through underwriters; |
| ● | to
or through broker-dealers (acting as agent or principal); |
| ● | in
“at the market” offerings, within the meaning of Rule 415(a)(4) of the Securities
Act, to or through a market maker or into an existing trading market, on an exchange or otherwise;
and/or |
| ● | directly
to purchasers, through a specific bidding or auction process or otherwise. |
The
securities may be sold at a fixed price or prices, which may be changed, at market prices prevailing at the time of sale, at prices relating
to the prevailing market prices or at negotiated prices.
Offers
to purchase offered securities may be solicited by agents designated by us from time to time. Any agent involved in the offer or sale
of the offered securities in respect of which this prospectus is delivered will be named, and any commissions payable by us will be set
forth, in the applicable prospectus supplement. Unless otherwise set forth in the applicable prospectus supplement, any agent will be
acting on a reasonable best efforts basis for the period of its appointment. Any agent may be deemed to be an underwriter, as that term
is defined in the Securities Act, of the offered securities so offered and sold.
We
will set forth in a prospectus supplement the terms of the offering of our securities, including:
| ● | the
name or names of any agents, underwriters or dealers; |
| ● | the
type of securities being offered; |
| ● | the
purchase price of our securities being offered and the net proceeds we expect to receive
from the sale; |
| ● | any
over-allotment options under which underwriters may purchase additional securities from us; |
| ● | any
agency fees or underwriting discounts and commissions and other items constituting agents’
or underwriters’ compensation; |
| ● | the
public offering price; |
| ● | any
discounts or concessions allowed or reallowed or paid to dealers; and |
| ● | any
securities exchanges on which such securities may be listed. |
If
offered securities are sold to the public by means of an underwritten offering, either through underwriting syndicates represented by
managing underwriters or directly by the managing underwriters, we will execute an underwriting agreement with an underwriter or underwriters,
and the names of the specific managing underwriter or underwriters, as well as any other underwriters, will be set forth in the applicable
prospectus supplement. In addition, the terms of the transaction, including commissions, discounts and any other compensation of the
underwriters and dealers, if any, will be set forth in the applicable prospectus supplement, which prospectus supplement will be used
by the underwriters to make resales of the offered securities. If underwriters are utilized in the sale of the offered securities, the
offered securities will be acquired by the underwriters for their own account and may be resold from time to time in one or more transactions,
including:
| ● | transactions
on the NASDAQ Capital Market or any other organized market where the securities may be traded; |
| ● | in
the over-the-counter market; |
| ● | in
negotiated transactions; or |
| ● | under
delayed delivery contracts or other contractual commitments. |
We
may grant to the underwriters options to purchase additional offered securities to cover over-allotments, if any, at the public
offering price with additional underwriting discounts or commissions, as may be set forth in the applicable prospectus supplement.
If we grant any over-allotment option, the terms of the over-allotment option will be set forth in the applicable prospectus
supplement.
We
may authorize agents or underwriters to solicit offers by certain types of institutional investors to purchase securities from us at
the public offering price set forth in the prospectus supplement pursuant to delayed delivery contracts providing for payment and delivery
on a specified date in the future. We will describe the conditions to these contracts and the commissions we must pay for solicitation
of these contracts in the prospectus supplement.
We
may indemnify agents, underwriters and dealers against specified liabilities, including liabilities incurred under the Securities Act,
or to contribution by us to payments they may be required to make in respect of such liabilities. Agents, underwriters or dealers, or
their respective affiliates, may be customers of, engage in transactions with or perform services for us or our respective affiliates,
in the ordinary course of business.
Unless
otherwise specified in the applicable prospectus supplement, each class or series of securities will be a new issue with no established
trading market, other than our common stock, which is traded on the NASDAQ Capital Market. We may elect to list any other class or series
of securities on any exchange and, in the case of our common stock, on any additional exchange. However, unless otherwise specified in
the applicable prospectus supplement, we will not be obligated to do so. It is possible that one or more underwriters may make a market
in a class or series of securities, but the underwriters will not be obligated to do so and may discontinue any market making at any
time without notice. We cannot give any assurance as to the liquidity of the trading market for any of the offered securities.
Any
underwriter may engage in over-allotment, stabilizing transactions, short-covering transactions and penalty bids in accordance with Regulation
M under the Securities Exchange Act of 1934, as amended, or the Exchange Act. Over-allotment involves sales in excess of the offering
size, which create a short position. Stabilizing transactions permit bids to purchase the underlying security so long as the stabilizing
bids do not exceed a specified maximum price. Syndicate-covering or other short-covering transactions involve purchases of the securities,
either through exercise of the over-allotment option or in the open market after the distribution is completed, to cover short positions.
Penalty bids permit the underwriters to reclaim a selling concession from a dealer when the securities originally sold by the dealer
are purchased in a stabilizing or covering transaction to cover short positions. Those activities may cause the price of the securities
to be higher than it would otherwise be. If commenced, the underwriters may discontinue any of the activities at any time.
To
comply with the securities laws of certain states, if applicable, the securities offered by this prospectus will be offered and sold
in those states only through registered or licensed brokers or dealers.
LEGAL
MATTERS
Certain
legal matters, including the validity of the issuance of the securities offered by this prospectus, will be passed upon for us by Stradling
Yocca Carlson & Rauth, P.C., Newport Beach, California.
EXPERTS
The
consolidated financial statements of Sunworks, Inc. as of December 31, 2021 and 2020 and for each of the two years in the period ended
December 31, 2021, appearing in Sunworks, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2021 have been audited
by KMJ Corbin & Company LLP, independent registered public accounting firm, as set forth in their report, which is incorporated herein
by reference. Such consolidated financial statements are incorporated herein by reference in reliance upon such report given on the authority
of such firm as experts in accounting and auditing.
INCORPORATION
OF CERTAIN DOCUMENTS BY REFERENCE
The
SEC allows us to “incorporate” into this prospectus information that we file with the SEC in other documents. This means
that we can disclose important information to you by referring to other documents that contain that information. Any information that
we incorporate by reference into this prospectus is considered part of this prospectus.
Information
contained in this prospectus and information that we file with the SEC in the future and incorporate by reference in this prospectus
automatically modifies and supersedes previously filed information, including information in previously filed documents or reports that
have been incorporated by reference in this prospectus, to the extent the new information differs from or is inconsistent with the old
information. Any statement so modified will be deemed to constitute a part of this prospectus only as so modified, and any statement
so superseded will be deemed not to constitute a part of this prospectus. For more information, see “About this Prospectus.”
We
incorporate by reference, as of their respective dates of filing, the documents listed below that we have filed with the SEC and any
future documents that we file with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, including any documents
filed after the date on which the registration statement of which this prospectus is a part is initially filed until the offering of
the securities covered by this prospectus has been completed, other than, in each case, documents or information deemed to have been
“furnished” and not “filed” in accordance with SEC rules:
| ● | our
Annual Report on Form 10-K for the fiscal year ended December 31, 2021 as filed with the
SEC on March 11, 2022 (our “Annual Report”); |
| | |
| ● | our
Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2022 as filed with the
SEC on May 16, 2022; |
| | |
| ● | the
information specifically incorporated by reference into our Annual Report on Form 10-K from
our Definitive Proxy Statement on Schedule 14A, filed with the SEC on April 29, 2022; |
| | |
| ● | our
Current Report on Form 8-K, as filed with the SEC on May 31, 2022; and |
| | |
| ● | the
description of our securities contained in Exhibit 4.1 to our Annual Report on Form 10-K
for the fiscal year ended December 31, 2021, filed with the SEC on March 11, 2022, including
any amendment or report filed for the purpose of updating such description. |
These
filings have not been included in or delivered with this prospectus. We will provide to each person, including any beneficial owner to
whom this prospectus is delivered, a copy of any document that is incorporated by reference in this prospectus. You may obtain a copy
of these documents, at no cost, from our website (www.sunworksusa.com) or by contacting us using the following information:
Jason
Bonfigt
Chief
Financial Officer
Sunworks,
Inc.
1555
Freedom Boulevard
Provo,
UT 84604
(385)
497-6955
Exhibits
to the documents will not be sent, however, unless those exhibits have specifically been incorporated by reference in this prospectus.
You
should rely only on the information contained in this prospectus, in any accompanying prospectus supplement, or in any document
incorporated by reference herein or therein. We have not authorized anyone to provide you with any different information. We take no
responsibility for, and can provide no assurance as to the reliability of, any other information that others may provide to you. The
information contained in this prospectus, in any applicable prospectus supplement, and in the documents incorporated by reference
herein or therein is accurate only as of the date such information is presented. Our business, financial condition, results of
operations and future prospects may have changed since those respective dates.
WHERE
YOU CAN FIND MORE INFORMATION
We
file annual, quarterly and current reports and other information with the SEC. Our filings with the SEC are available on the SEC’s
website at www.sec.gov, which contains reports, proxy and information statements, and other information regarding issuers that file electronically.
This
prospectus is part of a registration statement that we filed with the SEC. As permitted by SEC rules, this prospectus and any accompanying
prospectus supplement that we may file, which form a part of the registration statement, do not contain all of the information that is
included in the registration statement. The registration statement contains more information regarding us and our securities, including
certain exhibits. You can obtain a copy of the registration statement from the SEC’s website.
$75,000,000
SUNWORKS,
INC.
Common
Stock
Preferred
Stock
Warrants
Units
PROSPECTUS
,
2022
PART
II
INFORMATION
NOT REQUIRED IN PROSPECTUS
ITEM
14. | OTHER
EXPENSES OF ISSUANCE AND DISTRIBUTION. |
The
following table sets forth an itemization of the various costs and expenses, other than underwriting discounts and commissions, payable
by us in connection with the issuance and distribution of the securities being registered hereunder. All of the amounts shown are estimated
except for the SEC registration fee.
SEC registration fee |
|
$ | 6,952.50 | |
FINRA filing fees |
|
$ | * | |
Legal fees and expenses |
|
$ | * | |
Accounting fees and expenses |
|
$ | * | |
Miscellaneous |
|
$ | * | |
Total expenses |
|
$ | * | |
* | These
fees and expenses depend on the securities offered and the number of issuances, and accordingly
cannot be estimated at this time |
ITEM
15. | INDEMNIFICATION
OF DIRECTORS AND OFFICERS. |
We
are incorporated under the laws of the State of Delaware. Section 145 of the DGCL provides that a Delaware corporation may indemnify
any persons who are, or are threatened to be made, parties to any threatened, pending or completed action, suit or proceeding, whether
civil, criminal, administrative or investigative (other than an action by or in the right of such corporation), by reason of the fact
that such person was an officer, director, employee or agent of such corporation, or is or was serving at the request of such corporation
as an officer, director, employee or agent of another corporation or enterprise. The indemnity may include expenses (including attorneys’
fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action,
suit or proceeding, provided that such person acted in good faith and in a manner he or she reasonably believed to be in or not opposed
to the corporation’s best interests and, with respect to any criminal action or proceeding, had no reasonable cause to believe
that his or her conduct was illegal. Section 145 of the DGCL further authorizes a corporation to purchase and maintain insurance on behalf
of any indemnified person against any liability asserted against and incurred by such person in any indemnified capacity, or arising
out of such person’s status as such, regardless of whether the corporation would otherwise have the power to indemnify such person
under the DGCL.
Section
102(b)(7) of the DGCL permits a corporation to provide in its certificate of incorporation that a director of the corporation shall not
be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duties as a director, except
for liability for any:
| ● | breach
of a director’s duty of loyalty to the corporation or its stockholders; |
| ● | act
or omission not in good faith or that involves intentional misconduct or a knowing violation
of law; |
| ● | unlawful
payment of dividends or redemption of shares; or |
| ● | transaction
from which the director derives an improper personal benefit. |
Our
certificate of incorporation, as amended, eliminates the liability for damages for breaches of fiduciary duty for our directors, to the
fullest extent permitted by the DGCL, and our bylaws provide that we must indemnify our directors and officers to the fullest extent
authorized by the DGCL and also pay expenses incurred in defending any such proceeding in advance of its final disposition upon delivery
of an undertaking, by or on behalf of an indemnified person, to repay all amounts so advanced if it should be determined ultimately that
such person is not entitled to be indemnified under this section or otherwise.
We
have an insurance policy covering our officers and directors with respect to certain liabilities, including liabilities arising under
the Securities Act or otherwise.
Any
underwriting agreement or similar agreement that we enter into in connection with an offer of securities pursuant to this registration
statement may provide for indemnification by any underwriters of us, our directors, our officers who sign the registration statement
and our controlling persons for some liabilities, including liabilities arising under the Securities Act.
± | Filed
herewith. |
| |
* | To
be filed by amendment to this registration statement, or as an exhibit to a document to be
incorporated by reference into this registration statement, in each case in connection with
a particular offering of the securities. |
The
undersigned registrant hereby undertakes:
(1)
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration
statement:
| (i) | To
include any prospectus required by Section 10(a)(3) of the Securities Act; |
| | |
| (ii) | To
reflect in the prospectus any facts or events arising after the effective date of this registration
statement (or the most recent post-effective amendment thereof) which, individually or in
the aggregate, represent a fundamental change in the information set forth in this registration
statement. Notwithstanding the foregoing, any increase or decrease in the volume of securities
offered (if the total dollar value of securities offered would not exceed that which was
registered) and any deviation from the low or high end of the estimated maximum offering
range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b)
if, in the aggregate, the changes in volume and price represent no more than 20% change in
the maximum aggregate offering price set forth in the “Calculation of Registration
Fee” table in the effective registration statement; and |
| | |
| (iii) | To
include any material information with respect to the plan of distribution not previously
disclosed in this registration statement or any material change to such information in this
registration statement; |
provided,
however, that paragraphs (i), (ii) and (iii) above do not apply if the information required to be included in a post-effective
amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant to Section 13 or
Section 15(d) of the Exchange Act that are incorporated by reference in the registration statement, or is contained in a form of prospectus
filed pursuant to Rule 424(b) that is part of the registration statement.
(2)
That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to
be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall
be deemed to be the initial bona fide offering thereof.
(3)
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
termination of the offering.
(4)
That, for the purpose of determining liability under the Securities Act to any purchaser:
| (i) | Each
prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part
of the registration statement as of the date the filed prospectus was deemed part of and
included in the registration statement; and |
| | |
| (ii) | Each
prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5) or (b)(7) as part of a
registration statement in reliance on Rule 430B relating to an offering made pursuant to
Rule 415(a)(1)(i), (vii) or (x) for the purpose of providing the information required by
Section 10(a) of the Securities Act shall be deemed to be part of and included in the registration
statement as of the earlier of the date such form of prospectus is first used after effectiveness
or the date of the first contract of sale of securities in the offering described in the
prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person
that is at that date an underwriter, such date shall be deemed to be a new effective date
of the registration statement relating to the securities in the registration statement to
which the prospectus relates, and the offering of such securities at that time shall be deemed
to be the initial bona fide offering thereof. Provided, however, that no statement
made in a registration statement or prospectus that is part of the registration statement
or made in a document
incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement
will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made
in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior
to such effective date. |
(5)
That, for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial
distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned
registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the
purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned
registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:
| (i) | Any
preliminary prospectus or prospectus of the undersigned registrant relating to the offering
required to be filed pursuant to Rule 424; |
| | |
| (ii) | Any
free writing prospectus relating to the offering prepared by or on behalf of the undersigned
registrant or used or referred to by the undersigned registrant; |
| | |
| (iii) | The
portion of any other free writing prospectus relating to the offering containing material
information about the undersigned registrant or its securities provided by or on behalf of
the undersigned registrant; and |
| | |
| (iv) | Any
other communication that is an offer in the offering made by an undersigned registrant to
the purchaser. |
(6)
That, for purposes of determining any liability under the Securities Act, each filing of the registrant’s annual report
pursuant to Section 13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s
annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall
be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that
time shall be deemed to be the initial bona fide offering thereof.
(7)
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling
persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of
the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the
event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or
paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is
asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will,
unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be
governed by the final adjudication of such issue.
SIGNATURES
Pursuant
to the requirements of the Securities Act, the registrant certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of Provo, State of Utah, on May 31, 2022.
|
SUNWORKS,
INC. |
|
|
|
By: |
/s/
Gaylon Morris |
|
|
Gaylon
Morris |
|
|
Chief
Executive Officer |
KNOW
ALL PERSONS BY THESE PRESENTS that each individual whose signature appears below constitutes and appoints Gaylon Morris and Jason Bonfigt,
and each of them, his or her true and lawful attorneys-in-fact and agents with full power of substitution, for him or her and in his
or her name, place and stead, in any and all capacities, to sign any and all amendments, including post-effective amendments, to this
registration statement, and to sign any registration statement for the same offering covered by this registration statement that is to
be effective upon filing pursuant to Rule 462(b) promulgated under the Securities Act, and all post-effective amendments thereto, and
to file the same, with all exhibits thereto and all documents in connection therewith, making such changes in this registration statement
as such attorneys-in-fact and agents so acting deem appropriate, with the SEC, granting unto said attorneys-in-fact and agents, and each
of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done with respect to the
offering of securities contemplated by this registration statement, as fully to all intents and purposes as he or she might or could
do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or his, her or their substitute
or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant
to the requirements of the Securities Act, this registration statement has been signed by the following persons in the capacities and
on the dates indicated.
Name |
|
Title |
|
Date |
|
|
|
|
|
/s/
Gaylon Morris |
|
Chief
Executive Officer and Director |
|
May
31, 2022 |
Gaylon
Morris |
|
(Principal
Executive Officer) |
|
|
|
|
|
|
|
/s/
Jason Bonfigt |
|
Chief
Financial Officer |
|
May
31, 2022 |
Jason
Bonfigt |
|
(Principal
Financial and Accounting Officer) |
|
|
|
|
|
|
|
/s/
Judith Hall |
|
Chairperson
of the Board |
|
May
31, 2022 |
Judith
Hall |
|
|
|
|
|
|
|
|
|
/s/
Stanley Speer |
|
Director |
|
May
31, 2022 |
Stanley
Speer |
|
|
|
|
|
|
|
|
|
/s/
Rhone Resch |
|
Director |
|
May
31, 2022 |
Rhone
Resch |
|
|
|
|
|
|
|
|
|
/s/
Patrick McCullough |
|
Director |
|
May
31, 2022 |
Patrick
McCullough |
|
|
|
|
Grafico Azioni Sunworks (NASDAQ:SUNW)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Sunworks (NASDAQ:SUNW)
Storico
Da Mag 2023 a Mag 2024